Sophie is Managing Partner at Partners4Access, a global consultancy 100% focused on orphan drug access. We support the biotechnology and pharmaceutical industry along their launch journey to help secure successful price, reimbursement and access for orphan drugs. Partners4Access has solid partnerships with clients supporting their strategy and operations to effectively ensure launch success.
At Partners4Access, we believe patients with rare diseases deserve the right to access the most appropriate treatment. Our vision is ensuring fair access for all key stakeholders. By that, we mean fair access to drugs for rare disease patients, fair value for those that fund treatments, access to the smartest clinical option for the disease expert and a fair return on investment for the orphan drug manufacturer. We work with our biotechnology clients in partnership, to think differently across 5 best practices, and smartly secure access for orphan drugs.
Sophie has worked in a range of disease therapy areas and has industry experience in both medical device and pharmaceutical industries, as such she has developed a solid appreciation of strategic challenges and opportunities facing companies. Through her time in industry she worked on several key product launches in both strategic planning and implementation. She has worked in global, regional and local teams which gives her a strong appreciation of real-life challenges in modern day healthcare organizations.
Sophie’s has enjoyed a successful 20 year commercial career within consultancy and industry. Prior to setting up Partners4Access, she worked at Alliance, PriceSpective, BMS, ConvaTec, SSL International and Smith & Nephew. In this time, Sophie has been involved in several product launches, organizational changes and acquisitions.